Erythropoietin: Use in a Critically Ill Patient Refusing a Blood Transfusion
To present a patient with a critically low haemoglobin due to anaemia of chronic disease who was treated with recombinant human erythropoietin (r HuEPO). Anaemia of chronic disease is usually treated with blood transfusion. Studies have shown that erythropoietin can increase production of red blood...
Gespeichert in:
| Veröffentlicht in: | Australian journal of hospital pharmacy 1997-02, Vol.27 (1), p.38-40 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 40 |
|---|---|
| container_issue | 1 |
| container_start_page | 38 |
| container_title | Australian journal of hospital pharmacy |
| container_volume | 27 |
| creator | Robinson, Maxine KF |
| description | To present a patient with a critically low haemoglobin due to anaemia of chronic disease who was treated with recombinant human erythropoietin (r HuEPO). Anaemia of chronic disease is usually treated with blood transfusion. Studies have shown that erythropoietin can increase production of red blood cells and haemoglobin. |
| doi_str_mv | 10.1002/jppr199727138 |
| format | Article |
| fullrecord | <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_jppr199727138</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JPPR199727138</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1948-a56cf2930b3b9a0bb588cec137124ea3f4c88111cc048042a3e68748734698423</originalsourceid><addsrcrecordid>eNp90EFLwzAUB_AgCs7p0Xu-QDUvyZrEm5apk4JlbOeSxlQzYlOSivTb2zFBvXh6j8fv_w5_hC6BXAEh9HrX9xGUElQAk0doRhiQLJdAjn_tp-gspd3EORNihsplHIe3GPrg7OC6G7xNFrsOa1xENzijvR_xyntc6cHZbsBr234k171O4s6H8II3UXdpfwvdOTpptU_24nvO0fZ-uSkes_L5YVXclpkBxWWmF7lpqWKkYY3SpGkWUhprgAmg3GrWciMlABhDuCScamZzKbgUjOdKcsrmKDv8NTGkFG1b99G96zjWQOp9FfWfKiYvD_7TeTv-j-unqlr_RL8Anvxh-w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Erythropoietin: Use in a Critically Ill Patient Refusing a Blood Transfusion</title><source>Access via Wiley Online Library</source><creator>Robinson, Maxine KF</creator><creatorcontrib>Robinson, Maxine KF</creatorcontrib><description>To present a patient with a critically low haemoglobin due to anaemia of chronic disease who was treated with recombinant human erythropoietin (r HuEPO). Anaemia of chronic disease is usually treated with blood transfusion. Studies have shown that erythropoietin can increase production of red blood cells and haemoglobin.</description><identifier>ISSN: 0310-6810</identifier><identifier>EISSN: 0310-6810</identifier><identifier>DOI: 10.1002/jppr199727138</identifier><language>eng</language><ispartof>Australian journal of hospital pharmacy, 1997-02, Vol.27 (1), p.38-40</ispartof><rights>1997 The Society of Hospital Pharmacists of Australia</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1948-a56cf2930b3b9a0bb588cec137124ea3f4c88111cc048042a3e68748734698423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjppr199727138$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjppr199727138$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Robinson, Maxine KF</creatorcontrib><title>Erythropoietin: Use in a Critically Ill Patient Refusing a Blood Transfusion</title><title>Australian journal of hospital pharmacy</title><description>To present a patient with a critically low haemoglobin due to anaemia of chronic disease who was treated with recombinant human erythropoietin (r HuEPO). Anaemia of chronic disease is usually treated with blood transfusion. Studies have shown that erythropoietin can increase production of red blood cells and haemoglobin.</description><issn>0310-6810</issn><issn>0310-6810</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNp90EFLwzAUB_AgCs7p0Xu-QDUvyZrEm5apk4JlbOeSxlQzYlOSivTb2zFBvXh6j8fv_w5_hC6BXAEh9HrX9xGUElQAk0doRhiQLJdAjn_tp-gspd3EORNihsplHIe3GPrg7OC6G7xNFrsOa1xENzijvR_xyntc6cHZbsBr234k171O4s6H8II3UXdpfwvdOTpptU_24nvO0fZ-uSkes_L5YVXclpkBxWWmF7lpqWKkYY3SpGkWUhprgAmg3GrWciMlABhDuCScamZzKbgUjOdKcsrmKDv8NTGkFG1b99G96zjWQOp9FfWfKiYvD_7TeTv-j-unqlr_RL8Anvxh-w</recordid><startdate>199702</startdate><enddate>199702</enddate><creator>Robinson, Maxine KF</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>199702</creationdate><title>Erythropoietin: Use in a Critically Ill Patient Refusing a Blood Transfusion</title><author>Robinson, Maxine KF</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1948-a56cf2930b3b9a0bb588cec137124ea3f4c88111cc048042a3e68748734698423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Robinson, Maxine KF</creatorcontrib><collection>CrossRef</collection><jtitle>Australian journal of hospital pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Robinson, Maxine KF</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Erythropoietin: Use in a Critically Ill Patient Refusing a Blood Transfusion</atitle><jtitle>Australian journal of hospital pharmacy</jtitle><date>1997-02</date><risdate>1997</risdate><volume>27</volume><issue>1</issue><spage>38</spage><epage>40</epage><pages>38-40</pages><issn>0310-6810</issn><eissn>0310-6810</eissn><abstract>To present a patient with a critically low haemoglobin due to anaemia of chronic disease who was treated with recombinant human erythropoietin (r HuEPO). Anaemia of chronic disease is usually treated with blood transfusion. Studies have shown that erythropoietin can increase production of red blood cells and haemoglobin.</abstract><doi>10.1002/jppr199727138</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0310-6810 |
| ispartof | Australian journal of hospital pharmacy, 1997-02, Vol.27 (1), p.38-40 |
| issn | 0310-6810 0310-6810 |
| language | eng |
| recordid | cdi_crossref_primary_10_1002_jppr199727138 |
| source | Access via Wiley Online Library |
| title | Erythropoietin: Use in a Critically Ill Patient Refusing a Blood Transfusion |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T09%3A19%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Erythropoietin:%20Use%20in%20a%20Critically%20Ill%20Patient%20Refusing%20a%20Blood%20Transfusion&rft.jtitle=Australian%20journal%20of%20hospital%20pharmacy&rft.au=Robinson,%20Maxine%20KF&rft.date=1997-02&rft.volume=27&rft.issue=1&rft.spage=38&rft.epage=40&rft.pages=38-40&rft.issn=0310-6810&rft.eissn=0310-6810&rft_id=info:doi/10.1002/jppr199727138&rft_dat=%3Cwiley_cross%3EJPPR199727138%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |